A lipid-lowering agent. Reversibly inhibits HMG-COA reductase, inhibits the cholesterol synthesis at the stage of mevinolinic acid and moderately reduces its intracellular concentration. The indications for the drug use include: primary hypercholesterolemia mainly of IIa and IIb types, under the ineffective diet treatment in patients with increased risk of coronary atherosclerosis, hypercholesterolemia combined with hypertriglyceridemia; prevention of coronary artery disease. The drug decreases the risk of myocardial infarction, the need for revascularization of the myocardium, deaths from cardiovascular system diseases.

An anti-climax combined drug which has estrogenic and gestagenic effect, restores the balance of endogenous hormones.

Estrogens regulate the development of the female reproductive system functions’ preservation, the formation of female secondary sex characteristics. The list of indications includes: vasomotor symptoms associated with estrogen deficiency in the body, osteoporosis associated with estrogen deficiency, atrophic urethritis and atrophic vaginitis.

Voveran SR is the special formulation of Voveran, developed for the suspended release of its active ingredients and, consequently, a prolonged period of action. Apart from this feature, it has no notable characteristics differentiating it from the original medicine – an analgesic that provides satisfying results in the treatment of moderate pain syndromes. It helps with a wide range of painful conditions allowing patients to stop the pain before it grows stronger or control it in case of chronic joint diseases. In general, the new form provides better results in particular in the treatment of prolonged pain.

Any dependence of the body on external influences is considered as human weakness and drug addiction. Perhaps one of the most common is nicotine addiction. Zyban helps to overcome it.